April 1, 2013
India Court Ruling Upholds Access to Cheaper, Generic Drugs
The Supreme Court denied efforts by Novartis to patent an anticancer drug by "evergreening" its chemistry, signaling India's commitment to price reductions for drugs, especially HIV drugs